Macrophage Pharma Ltd, a two-year old company set up to advance small molecule drugs targeting tumour-associated macrophages, has raised £9 million in Series A finance from specialist oncology investors. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals Company News
